Holen Sie sich die Stockscreener-App
1.16
1.75%
0.02
Handel nachbörslich:
1.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
Cytosorbents Corp Q2 2025 Earnings Call Highlights - MSN
Is now a turning point for Cytosorbents CorporationJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - Newser
Why Cytosorbents Corporation stock attracts strong analyst attentionEarnings Recap Summary & Daily Entry Point Alerts - Newser
Technical signs of recovery in Cytosorbents Corporation2025 Macro Impact & Step-by-Step Trade Execution Guides - Newser
What recovery options are there for Cytosorbents CorporationRisk Management & Technical Pattern Based Buy Signals - Newser
How sentiment analysis helps forecast Cytosorbents CorporationQuarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Published on: 2025-08-12 20:31:12 - Newser
Sector ETF performance correlation with Cytosorbents Corporation [July 2025 Drop Watch]Risk Controlled Swing Trade Alerts - Newser
Is this a good reentry point in Cytosorbents CorporationFree Daily Chart Pattern Stock Forecast - Newser
Is Cytosorbents Corporation reversing from oversold territory2025 Trading Volume Trends & Daily Growth Stock Tips - Newser
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2025 Earnings Call Transcript - Insider Monkey
Exit strategy if you’re trapped in Cytosorbents CorporationEquity Market Return Forecast Model Update - Newser
Can volume confirm reversal in Cytosorbents CorporationExit Strategy Guide With Risk Control Plan - Newser
What institutions are buying Cytosorbents Corporation stock now5-Year Price Trend Summary and Analysis - Newser
Will Cytosorbents Corporation continue its uptrendFree Long Hold Safe Return Strategy - Newser
Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Cytosorbents Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
How to forecast Cytosorbents Corporation trends using time seriesHigh Return Strategy with Low Risk - Newser
How Cytosorbents Corporation stock performs during market volatilityTechnical Screener for High Growth Stocks - Newser
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips - Investing.com
CytoSorbents Corp (CTSO) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
CytoSorbents Reports Positive Q2 2025 Financial Results - TipRanks
CTSO: Analyst Jason Kolbert Maintains "Buy" Rating and $10 Price Target | CTSO Stock News - GuruFocus
Cytosorbents Corp reports results for the quarter ended June 30Earnings Summary - TradingView
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Reversal indicators forming on Cytosorbents Corporation stockFree Wealth Building Stock Market Ideas - Newser
What MACD signals say about Cytosorbents CorporationWeekly Market Direction and Sector Summary - Newser
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
How to recover losses in Cytosorbents Corporation stockBuy and Hold Return Summary with Charts - Newser
Tools to assess Cytosorbents Corporation’s risk profileFree Real Time Alerts Based on AI Prediction - Newser
Is Cytosorbents Corporation stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Cytosorbents Corporation stockBuild a portfolio that delivers consistent profits - Jammu Links News
Breakthrough Sepsis Treatment: CytoSorb Therapy Achieves 70% Survival Rate in Latest Clinical Studies - Stock Titan
CytoSorbents Leads a New Era in Sepsis Treatment - Nasdaq
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):